Skip to content
Equity Capital Market
  • Privacy Policy
  • Start Here
  • Research
    • LPTH case study
    • PLUG case study
    • STDN case study
  • IPO & Public Offerings
  • Economy & Macro
  • Latest
  • Stock Market
  • Market Education
  • Energy & Commodities
  • Capital Markets
  • Federal Reserve & Rates
  • About
  • Contact
  • Guides
    • Options guides
    • Bonds & Rates guides
    • Valuation guides
    • IPOs guides

life sciences m&a

Merck KGaA Buys Bio-Techne for $11.3B; TECH Pops 20%

November 13, 2026June 26, 2026 by Bruno M.
Merck KGaA Buys Bio-Techne for $11.3B; TECH Pops 20%

Merck KGaA acquires Bio-Techne for $11.3B in cash at $73/share, a 24% premium. TECH jumped 20% to $70.70 and the arb spread of 3.2% signals a tight deal.

Categories Stock Market Tags bio-techne acquisition, biotech tools, life sciences m&a, merck kgaa, merger arbitrage, stock market

Explore ECMSource

New here? Begin with our guide to the site, then explore the subjects that match what you want to understand.

  • Start Here
  • Market Education
  • Stock Market
  • Capital Markets
  • Federal Reserve & Rates

Recent Posts

  • Intuit Sells Mailchimp to Bending Spoons for $3.68 Billion
  • Anthropic (ANT) Lock-Up Schedule: 23 Release Dates and the Quiet Period
  • Walmart Q3 FY27: E-Commerce Up 17%, Guidance Raised Again
  • Anthropic (ANT) IPO Live: First-Day Trading Tracker After $83 Pricing
  • Required Minimum Distributions: Age 73 Rules and Math Explained

Subscribe to Our Newsletter

Oh hi there 👋
It’s nice to meet you.

Sign up to receive awesome content in your inbox, every month.

We don’t spam! Read our privacy policy for more info.

Check your inbox or spam folder to confirm your subscription.

  • Privacy Policy
  • Editorial Policy
  • Corrections Policy
  • Financial Disclaimer
  • Contact
  • About Bruno M.
  • Investor Tools
© 2026 Equity Capital Market • Built with GeneratePress